PharVision Advisers’s Baytex Energy BTE Stock Holding History

PharVision Advisers’s Portfolio BTE Stock Details BTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$78.2K	Buy	+19,546	New	+$90.3K	1.47%	35

Other funds holding BTE

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

JCA

Juniper Capital Advisors Houston, Texas $218M AUM 120.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Ninepoint Partners Toronto, Ontario, Canada $1.31B AUM 46.75% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

WCCM

Webs Creek Capital Management Dallas, Texas $528M AUM 69.69% 1-Year Est. Return

PharVision Advisers's BTE Position: Q2 2026 in Review

PharVision Advisers opened a new position in Baytex Energy (BTE) in Q2 2026: 19,546 shares worth $78.2K. The stake represents 1.47% of the portfolio and ranks #35 among its holdings.

186 funds tracked by Wall St. Rank hold BTE as of Q2 2026.

PharVision Advisers held 19,546 shares of Baytex Energy worth $78.2K as of Q2 2026.
Baytex Energy was a new PharVision Advisers position in Q2 2026.
Baytex Energy made up 1.47% of PharVision Advisers's portfolio in Q2 2026, its #35 holding.
186 funds tracked by Wall St. Rank held Baytex Energy as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.